Search results for CDX2 antibody

PE Anti-CDX2 antibody [EPR2764Y], Abcam, AB303008

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

CDX2 Antibody (YA4451)(PBS only), MedChemexpress, HY-P84754A

CDX2 Antibody (YA4451) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDX2.

CDX2 antibody [PCRP-CDX2-1A3], Genetex, GTX18049

Anti-CDX2 antibody [CDX2/1690], Abcam, AB217884

APC Anti-CDX2 antibody [EPR2764Y], Abcam, AB303009

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Homeobox Protein CDX-2 (CDX2) Antibody, Abbexa, abx159428

CDX2 Antibody is a Mouse Monoclonal against CDX2.

Homeobox Protein CDX-2 (CDX2) Antibody, Abbexa, abx327918

CDX2 Antibody is a Rabbit Polyclonal against CDX2.

Homeobox Protein CDX-2 (CDX2) Antibody, Abbexa, abx032694

The caudal type homeo box transcription factors 1 (CDX1) and 2 (CDX2) are candidates for directing intestinal development, differentiation, and maintenance of the intestinal phenotype. CDX1 and CDX2 expression is widely present in the human intestinal and colonic mucosae, but not in the gastric mucosa, suggesting a possible role in the terminal differentiation of the intestine. Increased CDX2 expression is associated with chronic atrophic gastritis. Detectable expression of CDX2 precedes expression of CDX1 during the progression of intestinal metaplasia, thus expression of CDX2 may trigger the initiation and development of intestinal metaplasia. Markedly reduced or absent CDX2 expression was noted by immunohistochemistry in 13 of 15 (87%) large cell minimally differentiated carcinomas (LCMDCs), whereas only 1 of the 25 (4%) differentiated adenocarcinomas (DACs) showed reduced CDX2 expression. Thus, a significant decrease in human CDX1 and/or CDX2 expression may be associated with colorectal tumorigenesis.

Homeobox Protein CDX-2 (CDX2) Antibody, Abbexa, abx016100

CDX2 Antibody is a Mouse Monoclonal against CDX2.

Homeobox Protein CDX-2 (CDX2) Antibody, Abbexa, abx403954

Human Homeobox Protein CDX-2 (CDX2) Antibody is a Mouse monoclonal against Homeobox Protein CDX-2 (CDX2).